Grb7 Upregulation Is a Molecular Adaptation to HER2 Signaling Inhibition Due to Removal of Akt-Mediated Gene Repression

The efficacy of anti-HER2 therapeutics, such as lapatinib and trastuzumab, is limited by primary and acquired resistance. Cellular adaptations that allow breast cancer cell to survive prolonged HER2 inhibition include de-repression of the transcription factor FOXO3A with consequent estrogen receptor...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Nencioni, Alessio, Cea, Michele, Garuti, Anna, Passalacqua, Mario, Raffaghello, Lizzia, Soncini, Debora, Moran, Eva, Zoppoli, Gabriele, Pistoia, Vito, Patrone, Franco, Ballestrero, Alberto
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2010
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2814867/
https://ncbi.nlm.nih.gov/pubmed/20126311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0009024
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller